|
Leading Cancer Expert
United Kingdom |
|
Date: 28 September 1999
Subject: the AngioTracker "anti-cancer" drug evaluation instrument
"Thank you for asking me to review your proposal on the development of a new instrument to monitor angiogenesis in breast cancer. ...I strongly support this approach to develop better measurements for clinical trials in this challenging area."
|
Leading Breast Surgeon
United Kingdom |
|
Date: 18 September 1999
Subject: the AngioTracker "anti-cancer" drug evaluation instrument
"Thank you for letting me see your proposal for instrumentation for monitoring angiogenesis in breast cancer. This is a very exciting and original proposal. All the smart money, according to the experts, is on angiogenesis...I will send you a recent paper of mine that provides the biological underpinning for [the use of anti-angiogenesis drugs in the treatment of breast cancer]. Good luck with your bid for the [John Logie] Baird award and I would love to be involved in the clinical evaluation phase."
|
Chief Executive Officer
Drug Delivery company
United Kingdom |
|
Date: 30 August 1999
Subject: the PhonoJect reusable needle-free injection device
"As previously discussed, [company name] would like to develop your patented phonophoresis device. In this relationship [company name] will be acting as a development company and will ultimately license a part finished/finished product to the eventual marketing partner(s)"
|
Research Director
Pharmaceutical company
United Kingdom |
|
Date: 26 August 1999
Subject: the PhonoJect reusable needle-free injection device
"Thank you for your presentation of the prototype phonophoresis needle free drug delivery system. I believe the concept of delivering drugs through the skin using ultrasound to be sound and an exciting opportunity in the healthcare research and development area. ...at a later stage in its development we would relish the opportunity to review your progress on this device."
|
Head of Business Development
Business Support Organisation
United Kingdom |
|
Date: 19 October 2000
Subject: the UltraStethoscope electronic auscultation device
"I confirm that [organisation name] are most interested in helping you develop your thoughts in this area and assess which course of action would be of most benefit to [HIC]. [organisation name] would be particularly interested in exploring the potential of establishing a company in the Highlands to manufacture and market the devices -- such a company would be eligible for financial assistance by way of grants and loans and we would consider equity participation in such a venture."
|
Chairman
Medical Device company
United States |
|
Date:
Subject: the UltraStethoscope electronic auscultation device
"During our assessment of the US marketplace for such a device, these unique features of connectivity, pick-up/amplification (through thick clothing), portability, and visual monitoring make this an extremely attractive product. [company name] would be most interested in...licensing or distributing the product for the US marketplace."
|
Managing Director
Medical Supplies company
United Kingdom |
|
Date:
Subject: the UltraStethoscope electronic auscultation device
"...I am delighted to hear of the progress you are making with the Ultrastethoscope. ...I will arrange for some market research to be carried out..." |
